Safety of dapsone as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected patients with allergy to trimethoprim/sulfamethoxazole

American Journal of Medicine

Volumn 100, Issue 6, 1996, Pages 611-616

  Beumont, Maria G ^a,c   Graziani, Amy ^a   Ubel, Peter A ^b   MacGregor, Rob Roy ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c Philadelphia Health Department   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMAZINE; DAPSONE; PENTAMIDINE;

ALLERGY; ANEMIA; ARTICLE; DISEASE CONTROL; FEVER; HEPATITIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; MAJOR CLINICAL STUDY; OPPORTUNISTIC INFECTION; OUTPATIENT; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RASH; RETROSPECTIVE STUDY;

EID: 0030175760     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(96)00008-3     Document Type: Article

References (29)

1. 1. Mallolas J, Zamora L, Gatell JM, et al. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine. AIDS. 1993;7:597-564.
2. 2. Jorde UP, Horowitz HW, Wormser GP. Utility of dapsone for prophylaxis of Pneumocystis carinii pneumonia in trimethoprim-sulfamethoxazole-intolerant, HIV-infected individuals. AIDS. 1993;7:355-359.
3. 3. Chaison RE, Keruly J, Richman DD, Moore RD. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The zidovudine epidemiology group. Arch Intern Med. 1992;152:2009-2013.
4. 4. Gallant JE, Moore RD, Chaisson RE. Prophylaxis for opportunistic infections in patients with HIV infection. Ann Intern Med. 1994;120:932-944.
5. 5. Coopman SA, Johnson RA, Platt R, Stern RS. Cutaneous disease and drug reactions in HIV infection. N Engl J Med. 1993;328:1670-1674
6. 6. Wright DN, Nelson RP Jr, Ledford DK, Fernandez-Caldas E, Trudeau WL, Lockey RF. Serum IgE and human immunodeficiency virus (HIV) infection. J Allergy Clin Immunol. 1990;85:445-452.
7. 7. Blum RN, Miller LA, Gaggini LC, Cohn DL. Comparative trial of dapsone versus trimethoprim/sulfamethoxazole for primary prophylaxis of Pneumocystis carinii pneumonia. J Acquired Immune Defic Syndr. 1992;5:341-347.
8. 8. Levine SJ, White DA. Pneumocystis carinii. Clin Chest Med. 1988;9:395-423.
9. 9. Stavola JJ, Noel GJ. Efficacy and Safety of dapsone prophylaxis against Pneumocystis carinii pneumonia in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1993;12:644-647.
10. 10. Kelly JW, Dooley DP, Lattuada CP, Smith CE. A severe, unusual reaction to trimethoprim-sulfamethoxazole in patients infected with human immunodeficiency virus. CID. 1992;14:1034-1039.
11. 11. Kovacs JA, Hiemenz JW, Macher AM, et al. Pneumocystis carinii pneumonia: a comparison between patients with the Acquired Immunodeficiency Syndrome and patients with other immunodeficiencies. Ann Intern Med. 1984;100:663-671.
12. 12. Gordin FM, Simon GL, Wofsy CB, Mills J. Adverse reactions to trimethoprimsulfamethoxazole in patients with the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1984;100:495-499.
13. 13. Carr A, Cooper DA, Penny R. Allergic manifestations of human immunodeficiency virus (HIV) infection. Clin Immunol. 1991;11:55-64.
14. 14. Mitsuyasu R, Groopman J. Cutaneous reaction to trimethoprim-sulfamethoxazole in patients with AIDS and Kaposi's sarcoma. N Engl J Med. 1983;308:1535-1536.
15. 15. Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprim-sulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis. 1993;167:180-185.
16. 16. Chan NH, Morgan AS, Graziani AL, MacGregor RR. Polypharmacy and adverse drug reactions in HIV-infected patients as a function of absolute CD4 lymphocyte count. The 32nd Interscience Conference on Antimicrobial Agents and Chemotherapy. 1992:1083(abst).
17. 17. Mohle-Bohetani J, Akula SJ, Holodniy M, Katzenstein D. The sulfone syndrome in a patient receiving dapsone prophylaxis for Pneumocystis carinii pneumonia. West J Med. 1992;156:303-306.
18. 18. Leoung GS, Mills J, Hopewell PC, Hughes W, Wofsy C. Dapsone-trimethoprim for Pneumocystis carinii pneumonia in the Acquired Immunodeficiency Syndrome. Ann Intern Med. 1986;105:45-48.
19. 19. Cockburn EM, Wood SM, Waller PC, Bleehen SS. Dapsone-induced agranulocytosis: spontaneous reporting data (letter). AIDS. 1994;1:102-103.
20. 20. Gibaldi M. Adverse drug effects: part II. Ann Pnarmacol. 1992;26:550-554.
21. 21. Lee BL, Medina I, Benowitz NL, Jacob P III, Wofsy CB, Mill J. Dapsone, trimethoprim, and sulfamethoxazole plasma levels during treatment of Pneumocystis pneumonia in patients with Acquired Immunodeficiency Syndrome (AIDS). Ann Intern Med. 1989;110:606-611.
22. 22. Stern RS. Systemic dapsone. Arch Dermatol. 1993;129:301-303.
23. 23. Medina I, Mills J, Leoung G, et al. Oral therapy for Pneumocystis carinii pneumonia in the Acquired Immunodeficiency Syndrome. N Engl J Med. 1990;323:776-782.
24. 24. Edelson PJ, Meroka CE, Friedman-Kien A. Dapsone, trimethoprim-sulfamethoxazole, and the Acquired Immunodeficiency Syndrome (letter). Ann Intern Med 1985;103:963.
25. 25. Carr A, Penny R, Cooper DA. Efficacy and safety of re-challenge with lowdose trimethoprim-sulfamethoxazole in previously hypersensitive HIV-infected patients. AIDS. 1993;7:65-71.
26. 26. Martin MA, Cox PH, Beck K, Styer CM, Beall GN. A comparison of the effectiveness of three regimens in prevention of Pneumocystis carinii pneumonia in Human Immunodeficiency Virus-infected patients. Arch Intern Med. 1992;152:523-528.
27. 27. Kemper CA, Tucker RM, Lang OS, et al. Low-dose dapsone prophylaxis of Pneumocystis carinii pneumonia in AIDS and AIDS-related complex. AIDS. 1990;4:1145-1148.
28. 28. Hughes WT, Kennedy W, Dugdale M, et al. Prevention of Pneumocystis carinii pneumonitis in AIDS patients with weekly dapsone (letter). Lancet. 1990;336:1006.
29. 29. Slavin MA, Hoy IF, Stewart K, Pettinger MB, Lucas CR, Kent SJ. Oral dapsone versus nebulized pentamidine for Pneumocystis carinii pneumonia prophylaxis: an open randomized prospective trial to assess efficacy and haematological toxicity. AIDS. 1992;6;1169-1174.